Effect of intravenous iron on endogenous erythropoietin and FGF-23 secretion in patients with chronic kidney disease

Introduction It has been observed that intravenous iron administration may suppress endogenous production of erythropoietin (EPO). We postulate that this effect may be mediated by increased FGF-23 secretion.Aim of the study To evaluate the short-term effect of intravenous iron sucrose administration...

Полное описание

Библиографические подробности

Главные авторы:	Katarzyna Muras-Szwedziak, Ewa Pawłowicz-Szlarska, Michał Nowicki
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Taylor & Francis Group 2023-12-01
Серии:	Renal Failure
Предметы:	Anemia iron erythropoietin fibroblast growth factor-23 inflammation
Online-ссылка:	https://www.tandfonline.com/doi/10.1080/0886022X.2022.2164305
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!